| Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles W Schneider-Brachert, V Tchikov, J Neumeyer, M Jakob, ... Immunity 21 (3), 415-428, 2004 | 651 | 2004 |
| Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and-3 activation M Heinrich, J Neumeyer, M Jakob, C Hallas, V Tchikov, ... Cell Death & Differentiation 11 (5), 550-563, 2004 | 449 | 2004 |
| Cathepsin D targeted by acid sphingomyelinase‐derived ceramide M Heinrich, M Wickel, W Schneider‐Brachert, C Sandberg, J Gahr, ... The EMBO journal, 1999 | 446 | 1999 |
| Regulation of TNFR1 and CD95 signalling by receptor compartmentalization S Schütze, V Tchikov, W Schneider-Brachert Nature reviews Molecular cell biology 9 (8), 655-662, 2008 | 400 | 2008 |
| Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome L Groesser, E Herschberger, A Ruetten, C Ruivenkamp, E Lopriore, ... Nature genetics 44 (7), 783-787, 2012 | 319 | 2012 |
| Sel1-like repeat proteins in signal transduction PRE Mittl, W Schneider-Brachert Cellular signalling 19 (1), 20-31, 2007 | 197 | 2007 |
| Streptococcal adhesion to novel low-shrink silorane-based restorative R Buergers, W Schneider-Brachert, S Hahnel, M Rosentritt, G Handel Dental Materials 25 (2), 269-275, 2009 | 173 | 2009 |
| Protein Subassemblies of the Helicobacter pylori Cag Type IV Secretion System Revealed by Localization and Interaction Studies S Kutter, R Buhrdorf, J Haas, W Schneider-Brachert, R Haas, W Fischer Journal of bacteriology 190 (6), 2161-2171, 2008 | 162 | 2008 |
| Helicobacter pylori and the risk of benign and malignant biliary tract disease M Bulajic, P Maisonneuve, W Schneider‐Brachert, P Müller, U Reischl, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2002 | 161 | 2002 |
| Induction of Maturation and Cytokine Release of Human Dendritic Cells by Helicobacter pylori K Kranzer, A Eckhardt, M Aigner, G Knoll, L Deml, C Speth, N Lehn, ... Infection and immunity 72 (8), 4416-4423, 2004 | 156 | 2004 |
| Curcumin blocks NF-κB and the motogenic response in Helicobacter pylori-infected epithelial cells A Foryst-Ludwig, M Neumann, W Schneider-Brachert, M Naumann Biochemical and biophysical research communications 316 (4), 1065-1072, 2004 | 156 | 2004 |
| Ceramide as an activator lipid of cathepsin D M Heinrich, M Wickel, S Winoto-Morbach, W Schneider-Brachert, T Weber, ... Cellular Peptidases in Immune Functions and Diseases 2, 305-315, 2002 | 155 | 2002 |
| Helicobacter pylori in human oral cavity and stomach R Bürgers, W Schneider‐Brachert, U Reischl, A Behr, KA Hiller, N Lehn, ... European journal of oral sciences 116 (4), 297-304, 2008 | 139 | 2008 |
| A Prospective, Randomized Study of Quadruple Therapy and High‐Dose Dual Therapy for Treatment of Helicobacter Pylori Resistant to Both Metronidazole and … S Miehlke, C Kirsch, W Schneider‐Brachert, C Haferland, M Neumeyer, ... Helicobacter 8 (4), 310-319, 2003 | 127 | 2003 |
| Inhibition of TNF receptor 1 internalization by adenovirus 14.7 K as a novel immune escape mechanism W Schneider-Brachert, V Tchikov, O Merkel, M Jakob, C Hallas, ML Kruse, ... The Journal of clinical investigation 116 (11), 2901-2913, 2006 | 122 | 2006 |
| 7‐Day Triple Therapy of Helicobacter pylori Infection with Levofloxacin, Amoxicillin, and High‐Dose Esomeprazole in Patients with Known Antimicrobial Sensitivity D Antos, W Schneider‐Brachert, E Bästlein, C Hänel, C Haferland, ... Helicobacter 11 (1), 39-45, 2006 | 121 | 2006 |
| Randomized trial of rifabutin‐based triple therapy and high‐dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and … S Miehlke, K Hansky, W Schneider‐Brachert, C Kirsch, A Morgner, ... Alimentary pharmacology & therapeutics 24 (2), 395-403, 2006 | 118 | 2006 |
| Efficacy of denture disinfection methods in controlling Candida albicans colonization in vitro R Buergers, M Rosentritt, W Schneider-Brachert, M Behr, G Handel, ... Acta Odontologica Scandinavica 66 (3), 174-180, 2008 | 116 | 2008 |
| One‐Week Once‐Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both … S Miehlke, W Schneider‐Brachert, C Kirsch, A Morgner, A Madisch, ... Helicobacter 13 (1), 69-74, 2008 | 107 | 2008 |
| Impact of Helicobacter pylori Virulence Factors and Compounds on Activation and Maturation of Human Dendritic Cells K Kranzer, L Söllner, M Aigner, N Lehn, L Deml, M Rehli, ... Infection and immunity 73 (7), 4180-4189, 2005 | 107 | 2005 |
